BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kennedy I, Francis H, Meng F, Glaser S, Alpini G. Diagnostic and therapeutic potentials of microRNAs in cholangiopathies. Liver Res 2017;1:34-41. [PMID: 29085701 DOI: 10.1016/j.livres.2017.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Meadows V, Francis H. MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants. AME Med J 2018;3:98. [PMID: 30506034 DOI: 10.21037/amj.2018.09.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kouroumalis E, Samonakis D, Voumvouraki A. Biomarkers for primary biliary cholangitis: current perspectives. Hepat Med 2018;10:43-53. [PMID: 29950909 DOI: 10.2147/HMER.S135337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gawish E, El-Monem EA, El-Abd M, Sobhy GA, Ghanem H. MicroRNA-499 rs3746444 polymorphism in Egyptian children with biliary atresia. Clin Exp Hepatol 2020;6:263-9. [PMID: 33145433 DOI: 10.5114/ceh.2020.99526] [Reference Citation Analysis]
4 Wang TH, Hsueh C, Chen CC, Li WS, Yeh CT, Lian JH, Chang JL, Chen CY. Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction. Int J Mol Sci 2018;19:E2687. [PMID: 30201903 DOI: 10.3390/ijms19092687] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
5 Lacerda JZ, Ferreira LC, Lopes BC, Aristizábal-Pachón AF, Bajgelman MC, Borin TF, Zuccari DAPC. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer. Microrna 2019;8:237-47. [PMID: 30806335 DOI: 10.2174/2211536608666190219095426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]